Publications:36
Video Visit Available
Accepting New Patients
- Mount Sinai Doctors
- Treats Children
- Video Visit Available
- Accepting New Patients
Jaime Chu, MD
Liver Transplantation, Pediatric Hepatology
RMTI Pediatric Liver Disease and Transplantation212-659-8060
View all locationsAbout Me
Dr. Jaime Chu is the Mount Sinai Endowed Professor of Pediatric Liver Research, the Associate Chief of the Division of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, Director of the Pediatric Physician-Scientist Residency Program, and Associate Director of the MD/PhD (MSTP) Program at the Mount Sinai Kravis Children’s Hospital, Mount Sinai’s Recanati/Miller Transplantation Institute, and Icahn School of Medicine at Mount Sinai. She received her B.A. magna cum laude from Harvard University and her M.D. from New York University School of Medicine. She completed her General Pediatrics residency training at Northwestern University/Children’s Memorial Hospital (now Lurie Children's Hospital of Chicago) at Northwestern University in Chicago, IL and her fellowship in Pediatric Gastroenterology, Hepatology, and Nutrition both at Children’s Memorial Hospital and at the Mount Sinai School of Medicine.
Dr. Chu is a physician-scientist in pediatric hepatology. She runs an NIH R01-funded basic research group that focuses on how sugar metabolism pathways drive liver development and disease. Her research has been awarded the Gilead Sciences Research Scholars Liver Disease Award, AASLD Foundation Bridge Award, K08, and R01 funding from the NIH/NIDDK to examine the role of mannose metabolism in liver fibrosis. Dr. Chu's clinical research includes participation as site PI and co-Investigator in NIH-funded consortia including a U01 Pediatric Acute Liver Failure, and other Industry-sponsored pediatric drug trials for genetic cholestatic liver disease, biliary atresia, and viral hepatitis. She is MPI on two R38 awards (NHLBI and NIAID), which support training in research during residency. Dr. Chu has served on study sections for the NIDDK and NCATS, and as a member of the AASLD Task Force on COVID-19. Dr. Chu's long-term goal is to utilize collaborative science and integrate basic and clinical research towards improving our understanding of the mechanisms underlying pediatric liver disease and to apply this knowledge towards the development of much needed therapeutic options for children with liver disease. For more information, please see the Chu Lab website: http://labs.icahn.mssm.edu/chulab/
Language
English
Position
PROFESSOR | Pediatrics, Hepatology
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Apoptosis/Cell Death, Biochemistry, Biomedical Sciences, Cancer, Cell Biology, Developmental Biology, Environmental Health, Extracellular Matrix, Fibrosis, Gastroenterology, Gene Discovery, Gene Expressions, Gene Regulation, Genetics, Glycobiology, Human Genetics and Genetic Disorders, Immunosuppression, Inflammation, Inflammatory Bowel Disease (IBD), Lipid Signaling, Liver, Metabolism, Metabolomics, Obesity, Oncogenes, Organ Donation, Organogenesis, Patient Care, Patient Centered Outcomes Research, Pediatrics, Phosphorylation, Post-Transcriptional Processing, Protein Structure/Function, Protein Translation, Regeneration, Signal Transduction, Transcriptional Activation and Repression, Translational Research, Transplantation, Tumor Suppressor Genes
Clinical Focus
- Acute and Chronic Liver Failure
- Alpha-1 Antitrypsin Deficiency
- Ascites
- Autoimmune Liver Disease
- Biliary Atresia
- Black Stool / Melena
- Chronic Liver Disease
- Cirrhosis
- End - Stage Liver Disease Management
- Gastrointestinal Bleeding
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Jaundice
- Liver Abscess
- Liver Failure/Liver Transplantation
- Liver Function Test
- Liver Tumors
- Metabolic Liver Disease
- Newborn Jaundice
- Nonalcoholic Fatty Liver Disease
- Obesity
Video
Education
MD, New York University School of Medicine
BA, Harvard University
Residency, Pediatrics
Children's Memorial Hospital
Fellowship, Pediatric Gastroenterology
Children's Memorial Hospital
Fellowship, Pediatric Gastroenterology
Mount Sinai Hospital
Certifications
American Board of Pediatrics
Awards
2024
NIH / NHLBI R38 StARR Program
NIH / NHLBI
2024
NIH / NIAID R38 StARR Program
NIH / NIAID
2020
NIH / NIDDK R01
National Institutes of Health
2019
AASLD Foundation Bridge Award
American Association for the Study of Liver Diseases Foundation
2017
Gilead Sciences Research Scholars Program in Liver Disease Award
Gilead Sciences, Inc.
2017
Art in Giving Research Scholar
The Rachel Molly Markoff Foundation
2013
NIH K08 Mentored Clinical Scientist Development Award
NIH/NIDDK
Research
Dr. Chu runs an R01-funded basic research group that focuses on how sugar metabolism pathways work together to sustain rapid cell growth in liver development and disease. Dr. Chu's long-term goal is to utilize collaborative science and integrate basic and clinical research towards improving our understanding of the mechanisms underlying pediatric liver disease and to apply this knowledge towards the development of much needed therapeutic options for children with liver disease. For more information, please see the Chu Lab website: http://labs.icahn.mssm.edu/chulab/
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) please click here for more information. Patients with Molina insurance should click here for more information. Mount Sinai’s contracts with Anthem and Molina expired on December 31.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban Metabolic Dysfunction-associated Steatotic Liver Disease Population. Xiaotao Zhang, Vikram Sivakumar, Alejandra Paredes-Marin, Asher Leviton, Augusto Villanueva, Meena B. Bansal, Julia Napoli, Christian Near, Dakota Trick, Hulya Kocyigit, Scott L. Friedman, Alyson Harty, Douglas Dieterich, Tatyana Kushner, Helen Adams, Ritu Agarwal, John Bucuvalas, Jaime Chu. Clinical Gastroenterology and Hepatology
- Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis. Alejandra Paredes-Marin, Julia Napoli, Vikram Sivakumar, Christian Near, Helen Adams, Alyson Harty, Ritu Agarwal, Douglas Dieterich, John Bucuvalas, Tatyana Kushner, Jaime Chu, Swati Antala, Asher Leviton, Scott L. Friedman, Augusto Villanueva, Rachel W. Smith, Xiaotao Zhang, Meena B. Bansal. Digestive Diseases and Sciences
- Progress and challenges in assessing allograft health in liver transplantation. Jaime Chu, John Bucuvalas. Liver Transplantation
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Chu has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.